Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 50090-7317

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 50090-7317). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (Image 01)

Chemical structure of venlafaxine hydrochloride, showing its molecular arrangement including a cyclohexane ring, methoxy-substituted benzene ring, and amine functional group.*

FDA Label Image

Image-02 (Image 02)

A scatter plot chart showing fold change and 90% confidence intervals for venlafaxine and its ODV metabolite in various special populations. The chart compares Cmax and AUC pharmacokinetic parameters relative to a reference value across hepatic impairment levels, renal impairment stages, CYP2D6 metabolism status, age over 60 years, and gender differences.*

FDA Label Image

Image-03 (Image 03)

A scatter plot chart showing fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax and AUC) of venlafaxine and its ODV metabolite when interacting with various drugs including ethanol, diazepam, cimetidine, ketoconazole (in CYP2D6 EMs and PMs), indinavir, metoprolol, imipramine, and lithium. The X-axis represents change relative to the reference value.*

FDA Label Image

Image-04 (Image 04)

A forest plot chart showing fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax and AUC) of various analytes affected by interacting drugs. The x-axis represents change relative to reference value, ranging from 0 to 3. Interacting drugs include ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium. Data points with error bars indicate fold changes for each analyte and pharmacokinetic measure.*

FDA Label Image

Label Image (Lbl500907317)

Venlafaxine Hydrochloride extended-release 75 mg capsules packaging label from A-S Medication Solutions. The label specifies a bottle of 30 capsules with storage instructions at 68 to 77 degrees Fahrenheit. NDC 50090-7317 is printed on the label, along with dosage and medication identifiers.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.